Feedback / Questions
onvatilimab (CI-8993) - Curis
emavusertib (CA-4948) - Curis, Dr. Reddy’s
https://www.prnewswire.com/news-releases/curis-announces-three-presentations-at-sitc-2022-301670717.html
Nov 7, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next